Nature Communications · 2016 · 69 citations · 47 references
Life SciencesDermatologyImmunologyAutoimmunityImmunopathologyInflammationB Cell BiologyB Cell RegulationCytokine BiologyInflammatory SignalingInflammatory Skin DiseasesInflammatory Skin DisordersB Cell Cytokine RegulationB-cell Mediated Skin DiseaseCytokine-mediated Skin InflammationInflammatory Skin ChangesInflammatory Skin ResponsesInterleukin-17 PathwayPsoriasis ImmunopathologyTopical Imiquimod
Epicutaneous application of Aldara cream containing the TLR7 agonist imiquimod (IMQ) to mice induces skin inflammation that exhibits many aspects of psoriasis, an inflammatory human skin disease. Here we show that mice depleted of B cells or bearing interleukin (IL)-10-deficient B cells show a fulminant inflammation upon IMQ exposure, whereas ablation of NFATc1 in B cells results in a suppression of Aldara-induced inflammation. In vitro, IMQ induces the proliferation and IL-10 expression by B cells that is blocked by BCR signals inducing NFATc1. By binding to HDAC1, a transcriptional repressor, and to an intronic site of the Il10 gene, NFATc1 suppresses IL-10 expression that dampens the production of tumour necrosis factor-α and IL-17 by T cells. These data indicate a close link between NFATc1 and IL-10 expression in B cells and suggest NFATc1 and, in particular, its inducible short isoform, NFATc1/αA, as a potential target to treat human psoriasis.
47
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Roberto Lande, Josh Gregorio, Valeria Facchinetti et al. · Nature · 2007 · 1.9K citations
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Gustavo Martínez, Renata M. Pereira, Tarmo Äijö et al. · Immunity · 2015 · 856 citations · Full text